Copper-induced epigenetic changes shape the clinical phenotype in wilson’s disease

Daniela Fanni, Clara Gerosa, Valeria Marina Nurchi, Rosita Cappai, Marta Mureddu, Peter Van Eyken, Luca Saba, Mirko Manchia, Gavino Faa

Research output: Contribution to journalReview articlepeer-review

7 Citations (Scopus)

Abstract

Wilson's disease is a congenital disorder of copper metabolism whose pathogenesis remains, at least in part, unknown. Subjects carrying the same genotype may show completely different phenotypes, differing for the age at illness onset or for the hepatic, neurologic or psychiatric clinical presentation. The inability to find a unequivocal correlation between the type of mutation in the ATPase copper transporting beta (ATP7B) gene and the phenotypic manifestation, has encouraged many authors to look for epigenetic factors interacting with the genetic changes. Here, the evidences regarding the ability of copper overload to change the global DNA methylation status are discussed.

Original languageEnglish
Pages (from-to)2707-2716
Number of pages10
JournalCurrent Medicinal Chemistry
Volume28
Issue number14
DOIs
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 Bentham Science Publishers.

ASJC Scopus Subject Areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Copper-induced epigenetic changes shape the clinical phenotype in wilson’s disease'. Together they form a unique fingerprint.

Cite this